Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (9446)
All Articles published online
|
Publishing Process of This Article
|
Apr 18, 2015 (publication date) through Nov 26, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Deng GL, Zeng S, Shen H. Chemotherapy and target therapy for hepatocellular carcinoma: New advances and challenges. World J Hepatol 2015; 7(5): 787-798 [PMID: 25914779 DOI: 10.4254/wjh.v7.i5.787] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v7/i5/787.htm |
| Number | Citing Articles |
| 1 |
Irmak Ayvaz, Dilara Sunay, Ece Sariyar, Esra Erdal, Zeynep Firtina Karagonlar. Three-Dimensional Cell Culture Models of Hepatocellular Carcinoma — a Review. Journal of Gastrointestinal Cancer 2021; 52(4): 1294 doi: 10.1007/s12029-021-00772-1
|
| 2 |
Abdulsalam Alhalmi, Sarwar Beg, Kanchan Kohli, Md. Waris, Tanuja Singh. Nanotechnology Based Approach for Hepatocellular Carcinoma Targeting. Current Drug Targets 2021; 22(7): 779 doi: 10.2174/1389450121999201209194524
|
| 3 |
Joaquim Moreno-Càceres, Isabel Fabregat. Apoptosis in liver carcinogenesis and chemotherapy. Hepatic Oncology 2015; 2(4): 381 doi: 10.2217/hep.15.27
|
| 4 |
HAO TANG, RONG-PING LI, PING LIANG, YA-LONG ZHOU, GUANG-WEI WANG. miR-125a inhibits the migration and invasion of liver cancer cells via suppression of the PI3K/AKT/mTOR signaling pathway. Oncology Letters 2015; 10(2): 681 doi: 10.3892/ol.2015.3264
|
| 5 |
Jella-Andrea Abraham, Olga Golubnitschaja. Time for Paradigm Change in Management of Hepatocellular Carcinoma: Is a Personalized Approach on the Horizon?. Personalized Medicine 2016; 13(5): 455 doi: 10.2217/pme-2016-0013
|
| 6 |
Zhongqiang Zhang, Xiao Tan, Jing Luo, Hongliang Yao, Zhongzhou Si, Jing-Shan Tong. The miR-30a-5p/CLCF1 axis regulates sorafenib resistance and aerobic glycolysis in hepatocellular carcinoma. Cell Death & Disease 2020; 11(10) doi: 10.1038/s41419-020-03123-3
|
| 7 |
Deniz Cansen Kahraman, Ebru Bilget Guven, Peri S. Aytac, Gamze Aykut, Birsen Tozkoparan, Rengul Cetin Atalay. A new triazolothiadiazine derivative inhibits stemness and induces cell death in HCC by oxidative stress dependent JNK pathway activation. Scientific Reports 2022; 12(1) doi: 10.1038/s41598-022-17444-0
|
| 8 |
Fan Wu, Wei‐Jia Chen, Lun Yan, Guo‐Qian Tan, Wei‐Tao Li, Xuan‐Jin Zhu, Xiao‐Chuan Ge, Jian‐Wei Liu, Bai‐Lin Wang. Mus81 knockdown improves chemosensitivity of hepatocellular carcinoma cells by inducing S‐phase arrest and promoting apoptosis through CHK1 pathway. Cancer Medicine 2016; 5(2): 370 doi: 10.1002/cam4.588
|
| 9 |
Jesús Rafael Rodríguez-Aguilera, Rebeca Pérez-Cabeza de Vaca, Nuria Guerrero-Celis, Gabriela Velasco-Loyden, Mariana Domínguez-López, Félix Recillas-Targa, Victoria Chagoya de Sánchez. Liver Cirrhosis - Debates and Current Challenges. 2019; doi: 10.5772/intechopen.83481
|
| 10 |
Yibin Deng, Zhongheng Wei, Meijin Huang, Guidan Xu, Wujun Wei, Bin Peng, Shunqiang Nong, Houji Qin. Long non‐coding RNA F11‐AS1 inhibits HBV‐related hepatocellular carcinoma progression by regulating NR1I3 via binding to microRNA‐211‐5p. Journal of Cellular and Molecular Medicine 2020; 24(2): 1848 doi: 10.1111/jcmm.14881
|
| 11 |
Wan-Jiang Xue, Ying Feng, Fei Wang, Yi-Bing Guo, Peng Li, Lei Wang, Yi-Fei Liu, Zhi-Wei Wang, Yu-Min Yang, Qin-Sheng Mao. Asialoglycoprotein receptor-magnetic dual targeting nanoparticles for delivery of RASSF1A to hepatocellular carcinoma. Scientific Reports 2016; 6(1) doi: 10.1038/srep22149
|
| 12 |
Chen-Jei Tai, Alagie Jassey, Ching-Hsuan Liu, Cheng-Jeng Tai, Christopher D. Richardson, Shu Hui Wong, Liang-Tzung Lin. Targeting Autophagy Augments Berberine-Mediated Cell Death in Human Hepatoma Cells Harboring Hepatitis C Virus RNA. Cells 2020; 9(4): 908 doi: 10.3390/cells9040908
|
| 13 |
Qiang Fei, Feihong Song, Xinwei Jiang, Han Hong, Xiaoyong Xu, Zhengkang Jin, Xiang Zhu, Binghua Dai, Jiamei Yang, Chengjun Sui, Minhui Xu. LncRNA ST8SIA6-AS1 promotes hepatocellular carcinoma cell proliferation and resistance to apoptosis by targeting miR-4656/HDAC11 axis. Cancer Cell International 2020; 20(1) doi: 10.1186/s12935-020-01325-5
|
| 14 |
Shaoshi Zhang, Wendi Bacon, Maikel P. Peppelenbosch, Folkert van Kemenade, Andrew Peter Stubbs. Deciphering Tumour Microenvironment of Liver Cancer through Deconvolution of Bulk RNA-Seq Data with Single-Cell Atlas. Cancers 2022; 15(1): 153 doi: 10.3390/cancers15010153
|
| 15 |
Wu Bi, Ji-chang Xiao, Rui-jie Liu, Liu-ying Zhou, Sai Zhang, Mei Yang, Peng-fei Zhang. Identification of a 3,3-difluorinated tetrahydropyridinol compound as a novel antitumor agent for hepatocellular carcinoma acting via cell cycle arrest through disturbing CDK7-mediated phosphorylation of Cdc2. Investigational New Drugs 2020; 38(2): 287 doi: 10.1007/s10637-019-00792-6
|
| 16 |
Surbhi Chouhan, Snahlata Singh, Dipti Athavale, Pranay Ramteke, Muralidharan Vanuopadath, Bipin G Nair, Sudarslal Sadasivan Nair, Manoj Kumar Bhat. Sensitization of hepatocellular carcinoma cells towards doxorubicin and sorafenib is facilitated by glucose-dependent alterations in reactive oxygen species, P-glycoprotein and DKK4. Journal of Biosciences 2020; 45(1) doi: 10.1007/s12038-020-00065-y
|
| 17 |
Shiri Davidi, Sara Jacobovitch, Anna Shteingauz, Antonia Martinez-Conde, Ori Braten, Catherine Tempel-Brami, Einav Zeevi, Roni Frechtel-Gerzi, Hila Ene, Eyal Dor-On, Tali Voloshin, Itai Tzchori, Adi Haber, Moshe Giladi, Adrian Kinzel, Uri Weinberg, Yoram Palti. Tumor Treating Fields (TTFields) Concomitant with Sorafenib Inhibit Hepatocellular Carcinoma In Vitro and In Vivo. Cancers 2022; 14(12): 2959 doi: 10.3390/cancers14122959
|
| 18 |
Jian Zhang, Xiuxiu Wang, Liang Cheng, Jiandong Yuan, Zhiyuan Zhong. SP94 peptide mediating highly specific and efficacious delivery of polymersomal doxorubicin hydrochloride to hepatocellular carcinoma in vivo. Colloids and Surfaces B: Biointerfaces 2021; 197: 111399 doi: 10.1016/j.colsurfb.2020.111399
|
| 19 |
Hongzhi Du, Yang Liu, Xudong Chen, Xiaowen Yu, Xiaoying Hou, Hongyang Li, Meixiao Zhan, Sensen Lin, Ligong Lu, Shengtao Yuan, Li Sun. DT-13 synergistically potentiates the sensitivity of gastric cancer cells to topotecan via cell cycle arrest in vitro and in vivo. European Journal of Pharmacology 2018; 818: 124 doi: 10.1016/j.ejphar.2017.10.014
|
| 20 |
Shuangyu Tian, Jinghang Li, Dongdong Wang, Yingchao Han, Honglian Dai, Lesan Yan. Sonodynamic-chemotherapy synergy with chlorin e6-based carrier-free nanoparticles for non-small cell lung cancer. Journal of Materials Chemistry B 2024; 12(13): 3282 doi: 10.1039/D4TB00009A
|
| 21 |
Yuanyuan Liu, Zhou Zhou, Xi Lin, Xiaofeng Xiong, Rui Zhou, Minglu Zhou, Yuan Huang. Enhanced Reactive Oxygen Species Generation by Mitochondria Targeting of Anticancer Drug To Overcome Tumor Multidrug Resistance. Biomacromolecules 2019; 20(10): 3755 doi: 10.1021/acs.biomac.9b00800
|
| 22 |
Jie Su, Linlin Jiang, Jingna Wu, Zhiyu Liu, Yuping Wu. Anti-tumor and anti-virus activity of polysaccharides extracted from Sipunculus nudus(SNP) on Hepg2.2.15. International Journal of Biological Macromolecules 2016; 87: 597 doi: 10.1016/j.ijbiomac.2016.03.022
|
| 23 |
Kin Fong Lei, Tai-Kun Liu, Ngan-Ming Tsang. Towards a high throughput impedimetric screening of chemosensitivity of cancer cells suspended in hydrogel and cultured in a paper substrate. Biosensors and Bioelectronics 2018; 100: 355 doi: 10.1016/j.bios.2017.09.029
|
| 24 |
Bingling Dai, Yujiao Ma, Tianfeng Yang, Mengying Fan, Runze Yu, Qi Su, Hongying Wang, Feng Liu, Changhua Yang, Yanmin Zhang. Synergistic effect of berberine and HMQ1611 impairs cell proliferation and migration by regulating Wnt signaling pathway in hepatocellular carcinoma. Phytotherapy Research 2019; 33(3): 745 doi: 10.1002/ptr.6267
|
| 25 |
Yuee Cai, Yingqi Xu, Hon Fai Chan, Xiaobin Fang, Chengwei He, Meiwan Chen. Glycyrrhetinic Acid Mediated Drug Delivery Carriers for Hepatocellular Carcinoma Therapy. Molecular Pharmaceutics 2016; 13(3): 699 doi: 10.1021/acs.molpharmaceut.5b00677
|
| 26 |
Po‐Han Tseng, Zong‐Lin Sie, Meng‐Chieh Liu, Han‐Syuan Lin, Wan‐Yu Yang, Ting‐Yu Lin, Hsing‐Pang Hsieh, Shih‐Che Hung, Chia‐Liang Cheng, Horng‐Dar Wang, Hsin‐Hou Chang, Chiou‐Hwa Yuh. Identification of Two Novel Small Compounds that Inhibit Liver Cancer Formation in Zebrafish and Analysis of Their Conjugation to Nanodiamonds to Further Reduce Toxicity. Advanced Therapeutics 2019; 2(12) doi: 10.1002/adtp.201900105
|
| 27 |
Hong-Bin Xu, Jun Fu, Fang Huang, Jing Yu. Guggulsterone sensitized drug-resistant human hepatocarcinoma cells to doxorubicin through a Cox-2/P-gp dependent pathway. European Journal of Pharmacology 2017; 803: 57 doi: 10.1016/j.ejphar.2017.03.045
|
| 28 |
F. Rahimi-Moghaddam, N. Azarpira, N. Sattarahmady. Evaluation of a nanocomposite of PEG-curcumin-gold nanoparticles as a near-infrared photothermal agent: an in vitro and animal model investigation. Lasers in Medical Science 2018; 33(8): 1769 doi: 10.1007/s10103-018-2538-1
|
| 29 |
Shrikant Barot, Ehab M. Abo-Ali, Daisy L. Zhou, Christian Palaguachi, Vikas V. Dukhande. Inhibition of glycogen catabolism induces intrinsic apoptosis and augments multikinase inhibitors in hepatocellular carcinoma cells. Experimental Cell Research 2019; 381(2): 288 doi: 10.1016/j.yexcr.2019.05.017
|
| 30 |
Yuanmin Pei, Xueling Sun, Xiwei Guo, Huashan Yin, Le Wang, Fugu Tian, Hongxi Jing, Xiaobo Liang, Jun Xu, Pengcheng Shi. FGF8 promotes cell proliferation and resistance to EGFR inhibitors via upregulation of EGFR in human hepatocellular carcinoma cells. Oncology Reports 2017; 38(4): 2205 doi: 10.3892/or.2017.5887
|
| 31 |
Licheng Zhu, Yu Lei, Jia Huang, Yahang An, Yanqiao Ren, Lei Chen, Huangxuan Zhao, Chuansheng Zheng. Recent advances in oncolytic virus therapy for hepatocellular carcinoma. Frontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1172292
|
| 32 |
Fujun Jin, Rongze Wang, Yexuan Zhu, Jingyi Chen, Wei Cao, Yiliang Wang, Yanting Wu, Xiaowei Song, Yunsheng Huang, Jun Dong, Zhe Ren. A novel quinolinylmethyl substituted ethylenediamine compound exerts anti-cancer effects via stimulating the accumulation of reactive oxygen species and NO in hepatocellular carcinoma cells. European Journal of Pharmacology 2020; 885: 173497 doi: 10.1016/j.ejphar.2020.173497
|
| 33 |
Zhi-Bin Zhao, Jie Long, Yang-Yang Zhao, Jing-Bo Yang, Wei Jiang, Qing-Zhi Liu, Kai Yan, Liang Li, Yu-Cai Wang, Zhe-Xiong Lian. Adaptive immune cells are necessary for the enhanced therapeutic effect of sorafenib-loaded nanoparticles. Biomaterials Science 2018; 6(4): 893 doi: 10.1039/C8BM00106E
|
| 34 |
Jialiang Wang, Yifan Lian, Yurong Gu, Hongbo Wang, Lin Gu, Yanlin Huang, Liang Zhou, Yuehua Huang. Synergistic effect of farnesyl transferase inhibitor lonafarnib combined with chemotherapeutic agents against the growth of hepatocellular carcinoma cells. Oncotarget 2017; 8(62): 105047 doi: 10.18632/oncotarget.22086
|
| 35 |
Erik Soule, Sanjay Lamsal, Chandana Lall, Jerry Matteo. Eye Opener to EtOH Ablation for Juxta-Cardiac Hepatocellular Carcinoma. Gastrointestinal Tumors 2018; 5(3-4): 109 doi: 10.1159/000495135
|
| 36 |
paria Tamaddon, Ghazale Perota, Rezvan Dehdari Vais, Naghmeh Sattarahmady. Cumulative Effect of a Gold-Poly(o-aminophenol) Nanocomposite and Doxorubicin in Photothermal Therapy, Sonodynamic Therapy, and Chemotherapy of Breast Cancer (MCF-7 Cell Line). Multidisciplinary Cancer Investigation 2023; 7(3): 9 doi: 10.61186/mci.7.3.9
|
| 37 |
Yulong Zheng, Lihua Jiang, Yongxian Hu, Cheng Xiao, Nong Xu, Jianying Zhou, Xinhui Zhou. Metallothionein 1H (MT1H) functions as a tumor suppressor in hepatocellular carcinoma through regulating Wnt/β-catenin signaling pathway. BMC Cancer 2017; 17(1) doi: 10.1186/s12885-017-3139-2
|
| 38 |
M. Gorgizadeh, N. Behzadpour, F. Salehi, F. Daneshvar, R. Dehdari Vais, R. Nazari-Vanani, N. Azarpira, M. Lotfi, N. Sattarahmady. A MnFe2O4/C nanocomposite as a novel theranostic agent in MRI, sonodynamic therapy and photothermal therapy of a melanoma cancer model. Journal of Alloys and Compounds 2020; 816: 152597 doi: 10.1016/j.jallcom.2019.152597
|
| 39 |
Saleh Daher, Muhammad Massarwa, Ariel A. Benson, Tawfik Khoury. Current and Future Treatment of Hepatocellular Carcinoma: An Updated Comprehensive Review. Journal of Clinical and Translational Hepatology 2018; 6(1): 1 doi: 10.14218/JCTH.2017.00031
|
| 40 |
Ncobile Bagezile Mdlovu, Kuen-Song Lin, Meng-Tzu Weng, Ndumiso Vukile Mdlovu. Formulation and in-vitro evaluations of doxorubicin loaded polymerized magnetic nanocarriers for liver cancer cells. Journal of the Taiwan Institute of Chemical Engineers 2021; 126: 278 doi: 10.1016/j.jtice.2021.06.059
|
| 41 |
Meiwan Chen, Xingzhi Zhou, Ruie Chen, Junlin Wang, Richard D. Ye, Yitao Wang, Chuanbin Wu, Ram I. Mahato. Nano-carriers for delivery and targeting of active ingredients of Chinese medicine for hepatocellular carcinoma therapy. Materials Today 2019; 25: 66 doi: 10.1016/j.mattod.2018.10.040
|
| 42 |
Chao-Jan Liu, Jung-Hua Lin, Man-Tzu Li, Er-Chieh Cho, Kuen-Chan Lee. Post-therapy via integrated curcumin and doxorubicin modified cerium-based UiO-66 MOFs using an antioxidant and anticancer therapeutic strategy. Journal of Materials Chemistry B 2024; doi: 10.1039/D4TB01206B
|
| 43 |
Hui Guo, Yan Zhong, Amanda L. Jackson, Leslie H. Clark, Josh Kilgore, Lu Zhang, Jianjun Han, Xiugui Sheng, Timothy P. Gilliam, Paola A. Gehrig, Chunxiao Zhou, Victoria L. Bae-Jump. Everolimus exhibits anti-tumorigenic activity in obesity-induced ovarian cancer. Oncotarget 2016; 7(15): 20338 doi: 10.18632/oncotarget.7934
|
| 44 |
Soojung Lee, Judee Grace E. Nemeño, Jeong Ik Lee. Repositioning Bevacizumab: A Promising Therapeutic Strategy for Cartilage Regeneration. Tissue Engineering Part B: Reviews 2016; 22(5): 341 doi: 10.1089/ten.teb.2015.0300
|
| 45 |
Hui Tang, Caixia Qiao, Zhenwei Guo, Ruixuan Geng, Zhao Sun, Yingyi Wang, Chunmei Bai. Necroptosis-related signatures identify two distinct hepatocellular carcinoma subtypes: Implications for predicting drug sensitivity and prognosis. Heliyon 2023; 9(7): e18136 doi: 10.1016/j.heliyon.2023.e18136
|
| 46 |
Seong Min Kim, Sang Eun Ha, Ho Jeong Lee, Shailima Rampogu, Preethi Vetrivel, Hun Hwan Kim, Venu Venkatarame Gowda Saralamma, Keun Woo Lee, Gon Sup Kim. Sinensetin Induces Autophagic Cell Death through p53-Related AMPK/mTOR Signaling in Hepatocellular Carcinoma HepG2 Cells. Nutrients 2020; 12(8): 2462 doi: 10.3390/nu12082462
|
| 47 |
Petra Grbčić, Elitza Petkova Markova Car, Mirela Sedić. Targeting Ceramide Metabolism in Hepatocellular Carcinoma: New Points for Therapeutic Intervention. Current Medicinal Chemistry 2020; 27(39): 6611 doi: 10.2174/0929867326666190911115722
|
| 48 |
Richa Bajpai. Theranostics and Precision Medicine for the Management of Hepatocellular Carcinoma. 2022; : 153 doi: 10.1016/B978-0-323-98806-3.00003-9
|
| 49 |
Bang-Bin Chen, Chao-Yu Hsu, Chih-Wei Yu, Po-Chin Liang, Chiun Hsu, Chih-Hung Hsu, Ann-Lii Cheng, Tiffany Ting-Fang Shih. Early perfusion changes within 1 week of systemic treatment measured by dynamic contrast-enhanced MRI may predict survival in patients with advanced hepatocellular carcinoma. European Radiology 2017; 27(7): 3069 doi: 10.1007/s00330-016-4670-2
|
| 50 |
Xin Qing, Wenjing Xu, Jingjing Zong, Xuanlong Du, Hao Peng, Yewei Zhang. Emerging treatment modalities for systemic therapy in hepatocellular carcinoma. Biomarker Research 2021; 9(1) doi: 10.1186/s40364-021-00319-3
|
| 51 |
Yuan Sun, Hai Xu, Xinju Chen, Xiaodong Li, Baoping Luo. Inhibition of mitochondrial respiration overcomes hepatocellular carcinoma chemoresistance. Biochemical and Biophysical Research Communications 2019; 508(2): 626 doi: 10.1016/j.bbrc.2018.11.182
|
| 52 |
Ting Xu, Shaojing Zhao, Changwei Lin, Xiuli Zheng, Minhuan Lan. Recent advances in nanomaterials for sonodynamic therapy. Nano Research 2020; 13(11): 2898 doi: 10.1007/s12274-020-2992-5
|
| 53 |
Asmaa F. Khafaga, Shaker A. Mousa, Lotfi Aleya, Mohamed M. Abdel-Daim. Three-dimensional (3D) cell culture: a valuable step in advancing treatments for human hepatocellular carcinoma. Cancer Cell International 2022; 22(1) doi: 10.1186/s12935-022-02662-3
|
| 54 |
Yuchang Yan, Tao Jiang, Zhenghan Yang, Zhenchang Wang, Erhu Jin, Zhenyu Pan. Application of Gemstone CT Spectroscopy in the Evaluation of Abnormal Enhancement of Lesion Margin After Radiofrequency Ablation of Hepatocellular Carcinoma. Iranian Journal of Radiology 2020; 17(4) doi: 10.5812/iranjradiol.99611
|
| 55 |
Atieh Pourbagheri‐Sigaroodi, Majid Momeny, Nima Rezaei, Fatemeh Fallah, Davood Bashash. Immune landscape of hepatocellular carcinoma: From dysregulation of the immune responses to the potential immunotherapies. Cell Biochemistry and Function 2024; 42(5) doi: 10.1002/cbf.4098
|
| 56 |
Cheol Park, Ji-Suk Jeong, Jin-Woo Jeong, Sung Ok Kim, Yong-Joo Kim, Gi-Young Kim, Su-Hyun Hong, Yung Hyun Choi. Ethanol extract of Kalopanax septemlobus leaf inhibits HepG2 human hepatocellular carcinoma cell proliferation via inducing cell cycle arrest at G 1 phase. Asian Pacific Journal of Tropical Medicine 2016; 9(4): 344 doi: 10.1016/j.apjtm.2016.03.003
|
| 57 |
Yanxia Gong, Jie Zhang, Xiang Wu, Tao Wang, Jia Zhao, Zhi Yao, Qingyu Zhang, Xi Liu, Xu Jian. Specific expression of proton-coupled oligopeptide transporter 1 in primary hepatocarcinoma-a novel strategy for tumor-targeted therapy. Oncology Letters 2017; 14(4): 4158 doi: 10.3892/ol.2017.6724
|
| 58 |
Yongmei Li, Hao Zhuang, Xinran Zhang, Yuan Li, Yun Liu, Xianfu Yi, Guoxuan Qin, Wen Wei, Ruibing Chen. Multiomics Integration Reveals the Landscape of Prometastasis Metabolism in Hepatocellular Carcinoma. Molecular & Cellular Proteomics 2018; 17(4): 607 doi: 10.1074/mcp.RA118.000586
|
| 59 |
Dongna Su. MCM7 affects the cisplatin resistance of liver cancer cells and the development of liver cancer by regulating the PI3K/Akt signaling pathway. Immunopharmacology and Immunotoxicology 2022; 44(1): 17 doi: 10.1080/08923973.2021.1991372
|
| 60 |
M. Gorgizadeh, N. Azarpira, M. Lotfi, F. Daneshvar, F. Salehi, N. Sattarahmady. Sonodynamic cancer therapy by a nickel ferrite/carbon nanocomposite on melanoma tumor: In vitro and in vivo studies. Photodiagnosis and Photodynamic Therapy 2019; 27: 27 doi: 10.1016/j.pdpdt.2019.05.023
|
| 61 |
Ying Han, Yinghui Peng, Yaojie Fu, Changjing Cai, Cao Guo, Shanshan Liu, Yiyi Li, Yihong Chen, Edward Shen, Kexin Long, Xinwen Wang, Jian Yu, Hong Shen, Shan Zeng. MLH1 Deficiency Induces Cetuximab Resistance in Colon Cancer via Her‐2/PI3K/AKT Signaling. Advanced Science 2020; 7(13) doi: 10.1002/advs.202000112
|
| 62 |
Naomi Nishio, Tadao Hasegawa, Ichiro Tatsuno, Masanori Isaka, Ken‐ichi Isobe. Female GADD34 mice develop age‐related inflammation and hepatocellular carcinoma. Geriatrics & Gerontology International 2017; 17(12): 2593 doi: 10.1111/ggi.13080
|
| 63 |
Zi Yin, Tingting Ma, Ye Lin, Xin Lu, Chuanzhao Zhang, Sheng Chen, Zhixiang Jian. Retracted: IL‐6/STAT3 pathway intermediates M1/M2 macrophage polarization during the development of hepatocellular carcinoma. Journal of Cellular Biochemistry 2018; 119(11): 9419 doi: 10.1002/jcb.27259
|
| 64 |
Bei Wang, Tan-Yang Zhou, Chun-Hui Nie, Da-Long Wan, Shu-Sen Zheng. Bigelovin, a sesquiterpene lactone, suppresses tumor growth through inducing apoptosis and autophagy via the inhibition of mTOR pathway regulated by ROS generation in liver cancer. Biochemical and Biophysical Research Communications 2018; 499(2): 156 doi: 10.1016/j.bbrc.2018.03.091
|
| 65 |
Hardev Singh, Seo Jin Kim, Dong Hoon Kang, Hye-Ri Kim, Amit Sharma, Won Young Kim, Chulhun Kang, Jong Seung Kim. Glycyrrhetinic acid as a hepatocyte targeting unit for an anticancer drug delivery system with enhanced cell type selectivity. Chemical Communications 2018; 54(87): 12353 doi: 10.1039/C8CC05175E
|
| 66 |
Selin Oncul, Gulsah Karakaya, Mutlu Dilsiz Aytemir, Ayse Ercan. A kojic acid derivative promotes intrinsic apoptotic pathway of hepatocellular carcinoma cells without incurring drug resistance. Chemical Biology & Drug Design 2019; 94(6): 2084 doi: 10.1111/cbdd.13615
|
| 67 |
Shubham Gupta, Sikandar Khan, Michal Kawka, Rohan Gujjuri, Ian Chau, Naureen Starling, David Cunningham, Long R Jiao, Tamara Gall. Clinical utility of clonal origin determination in managing recurrent hepatocellular carcinoma. Expert Review of Gastroenterology & Hepatology 2021; 15(10): 1159 doi: 10.1080/17474124.2021.1967144
|
| 68 |
Heba Taha, Nourhan Elfar, Hesham Haffez, Zeineb A. Hassan. Raptinal silver nanoparticles: new therapeutic advances in hepatocellular carcinoma mouse model. Naunyn-Schmiedeberg's Archives of Pharmacology 2021; 394(2): 279 doi: 10.1007/s00210-020-01973-4
|
| 69 |
Sarina Mokhtari, Mehran Solati-Hashjin, Zahra Khosrowpour, Mazaher Gholipourmalekabadi. Layered double hydroxide-galactose as an excellent nanocarrier for targeted delivery of curcumin to hepatocellular carcinoma cells. Applied Clay Science 2021; 200: 105891 doi: 10.1016/j.clay.2020.105891
|
| 70 |
Praful R. Nair, Cory Alvey, Xiaoling Jin, Jerome Irianto, Irena Ivanovska, Dennis E. Discher. Filomicelles Deliver a Chemo-Differentiation Combination of Paclitaxel and Retinoic Acid That Durably Represses Carcinomas in Liver to Prolong Survival. Bioconjugate Chemistry 2018; 29(4): 914 doi: 10.1021/acs.bioconjchem.7b00816
|
| 71 |
Jianrong Cao, Keze Hong, Chengqi Lv, Weiting Jiang, Qi Chen, Rongze Wang, Yong Wang. Reduction-sensitive polymeric carrier for the targeted delivery of a quinazoline derivative for enhanced generation of reactive oxygen species against cancer. Biomaterials Science 2024; 12(10): 2626 doi: 10.1039/D3BM02136J
|
| 72 |
Jun Young Park, Ju Ri Chae, Ye Lim Cho, Youndong Kim, Dasom Lee, Jeong Kyun Lee, Won Jun Kang. Targeted Therapy of Hepatocellular Carcinoma Using Gemcitabine-Incorporated GPC3 Aptamer. Pharmaceutics 2020; 12(10): 985 doi: 10.3390/pharmaceutics12100985
|
| 73 |
Bingting Yu, Ruslan Mamedov, Gwenny M. Fuhler, Maikel P. Peppelenbosch. Drug Discovery in Liver Disease Using Kinome Profiling. International Journal of Molecular Sciences 2021; 22(5): 2623 doi: 10.3390/ijms22052623
|
| 74 |
Ali Mahmoudi, Prashant Kesharwani, Muhammed Majeed, Yong Teng, Amirhossein Sahebkar. Recent advances in nanogold as a promising nanocarrier for curcumin delivery. Colloids and Surfaces B: Biointerfaces 2022; 215: 112481 doi: 10.1016/j.colsurfb.2022.112481
|
| 75 |
Luana Vittoria Bauso, Valeria La Fauci, Serena Munaò, Desirèe Bonfiglio, Alessandra Armeli, Noemi Maimone, Clelia Longo, Giovanna Calabrese. Biological Activity of Natural and Synthetic Peptides as Anticancer Agents. International Journal of Molecular Sciences 2024; 25(13): 7264 doi: 10.3390/ijms25137264
|
| 76 |
Caixia Xia, Liyan Shui, Guohua Lou, Bingjue Ye, Wei Zhu, Jing Wang, Shanshan Wu, Xiao Xu, Long Mao, Wanhong Xu, Zhi Chen, Yanning Liu, Min Zheng. 0404 inhibits hepatocellular carcinoma through a p53/miR-34a/SIRT1 positive feedback loop. Scientific Reports 2017; 7(1) doi: 10.1038/s41598-017-04487-x
|
| 77 |
Iftikhar Ali Khawar, Jong Kook Park, Eun Sun Jung, Myung Ah Lee, Suhwan Chang, Hyo-Jeong Kuh. Three Dimensional Mixed-Cell Spheroids Mimic Stroma-Mediated Chemoresistance and Invasive Migration in hepatocellular carcinoma. Neoplasia 2018; 20(8): 800 doi: 10.1016/j.neo.2018.05.008
|
| 78 |
Lixia Chen, Yitian He, Jinshuai Lan, Zhe Li, Donghao Gu, Wenlong Nie, Tong Zhang, Yue Ding. Advancements in nano drug delivery system for liver cancer therapy based on mitochondria-targeting. Biomedicine & Pharmacotherapy 2024; 180: 117520 doi: 10.1016/j.biopha.2024.117520
|
| 79 |
You-Liang Lai, Kai-Hung Wang, Hsing-Pang Hsieh, Wan-Ching Yen. Novel FLT3/AURK multikinase inhibitor is efficacious against sorafenib-refractory and sorafenib-resistant hepatocellular carcinoma. Journal of Biomedical Science 2022; 29(1) doi: 10.1186/s12929-022-00788-0
|
| 80 |
Hongzhi Du, Yue Huang, Xiaoying Hou, Xingping Quan, Jingwei Jiang, Xiaohui Wei, Yang Liu, Hongyang Li, Puhai Wang, Meixiao Zhan, Xun Ai, Ligong Lu, Shengtao Yuan, Li Sun. Two novel camptothecin derivatives inhibit colorectal cancer proliferation via induction of cell cycle arrest and apoptosis in vitro and in vivo. European Journal of Pharmaceutical Sciences 2018; 123: 546 doi: 10.1016/j.ejps.2018.08.018
|
| 81 |
Yang Liu, Heng Yang, Qiang Guo, Tingting Liu, Yong Jiang, Mingbo Zhao, Kewu Zeng, Pengfei Tu. Cucurbitacin E Inhibits Huh7 Hepatoma Carcinoma Cell Proliferation and Metastasis via Suppressing MAPKs and JAK/STAT3 Pathways. Molecules 2020; 25(3): 560 doi: 10.3390/molecules25030560
|
| 82 |
K. K. Dar, S. Ali, M. Ejaz, S. Nasreen, N. Ashraf, S. F. Gillani, N. Shafi, S. Safeer, M. A. Khan, S. Andleeb, T. A. Mughal. In vivo induction of hepatocellular carcinoma by diethylnitrosoamine and pharmacological intervention in Balb C mice using Bergenia ciliata extracts. Brazilian Journal of Biology 2019; 79(4): 629 doi: 10.1590/1519-6984.186565
|
| 83 |
Hui Tong, Tao Li, Weihua Qiu, Zhecheng Zhu. Claudin‑1 silencing increases sensitivity of liver cancer HepG2 cells to 5‑fluorouracil by inhibiting autophagy. Oncology Letters 2019; doi: 10.3892/ol.2019.10967
|
| 84 |
Li Wang, Yaqiong Zhan, Zhe Wu, Mengjia Lin, Xuehang Jin, Lushun Jiang, Yunqing Qiu. A novel multitarget kinase inhibitor BZG with potent anticancer activity in vitro and vivo enhances efficacy of sorafenib through PI3K pathways in hepatocellular carcinoma cells. Biomedicine & Pharmacotherapy 2020; 125: 110033 doi: 10.1016/j.biopha.2020.110033
|
| 85 |
Jasmine Baby, Aswathy R. Devan, Ayana R. Kumar, Jaggaiah N. Gorantla, Bhagyalakshmi Nair, Thanatharayil Sathian Aishwarya, Lekshmi R. Nath. Cogent role of flavonoids as key orchestrators of chemoprevention of hepatocellular carcinoma: A review. Journal of Food Biochemistry 2021; 45(7) doi: 10.1111/jfbc.13761
|
| 86 |
Hirayuki Enomoto, Hideji Nakamura, Weidong Liu, Shuhei Nishiguchi. Hepatoma-Derived Growth Factor: Its Possible Involvement in the Progression of Hepatocellular Carcinoma. International Journal of Molecular Sciences 2015; 16(6): 14086 doi: 10.3390/ijms160614086
|
| 87 |
Mou-Bo Si, Pei-Jing Yan, Xiang-Yong Hao, Zhen-Ying Du, Hong-Wei Tian, Jia Yang, Cai-Wen Han, Ke-Hu Yang, Tian-Kang Guo. Efficacy and safety of radiofrequency ablation versus minimally invasive liver surgery for small hepatocellular carcinoma: a systematic review and meta-analysis. Surgical Endoscopy 2019; 33(8): 2419 doi: 10.1007/s00464-019-06784-0
|
| 88 |
Hongliang Du, Mengrui Liu, Aihua Yu, Jianbo Ji, Guangxi Zhai. Insight into the role of dual-ligand modification in low molecular weight heparin based nanocarrier for targeted delivery of doxorubicin. International Journal of Pharmaceutics 2017; 523(1): 427 doi: 10.1016/j.ijpharm.2017.03.065
|
| 89 |
Jian Zhang, Chunyan Fang, Meihua Qu, Huina Wu, Xuejuan Wang, Hongan Zhang, Hui Ma, Zhaolin Zhang, Yongxue Huang, Lihong Shi, Shujuan Liang, Zhiqin Gao, Weiguo Song, Xuejian Wang. CD13 Inhibition Enhances Cytotoxic Effect of Chemotherapy Agents. Frontiers in Pharmacology 2018; 9 doi: 10.3389/fphar.2018.01042
|
| 90 |
Hongyan Xue, Guo-Yan Tian. MiR-429 regulates the metastasis and EMT of HCC cells through targeting RAB23. Archives of Biochemistry and Biophysics 2018; 637: 48 doi: 10.1016/j.abb.2017.11.011
|
| 91 |
Yu-Chun Lin, Bao-Hong Lee, Jassey Alagie, Ching-Hua Su. Combination treatment of ergosterol followed by amphotericin B induces necrotic cell death in human hepatocellular carcinoma cells. Oncotarget 2017; 8(42): 72727 doi: 10.18632/oncotarget.20285
|
| 92 |
Mahfoozur Rahman, Waleed H Almalki, Majed Alrobaian, Jawed Iqbal, Saad Alghamdi, Khalid S Alharbi, Nabil K Alruwaili, Abdul Hafeez, Adil Shaharyar, Tanuja Singh, Mohammad Waris, Vikas Kumar, Sarwar Beg. Nanocarriers-loaded with natural actives as newer therapeutic interventions for treatment of hepatocellular carcinoma. Expert Opinion on Drug Delivery 2021; 18(4): 489 doi: 10.1080/17425247.2021.1854223
|
| 93 |
Tian Li, An-Di Zhou, Li-Fei Bai, Xiao-Yang Zhang, Yu-Ting Zhou, Hai-Li Yang, Le-Tian Xu, Xin-Qin Guo, Xi-Yu Zhu, Dong-Jin Wang, Hong-Wei Gu, Xiao-Ming Wang. Design, synthesis, and anticancer activity of three novel palbociclib derivatives. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.959322
|
| 94 |
Yu-xian Huang, Xin-tong Chen, Kun-yuan Guo, Yu-hua Li, Bing-yi Wu, Chao-yang Song, Yan-jie He. Sunitinib Induces NK-κB-dependent NKG2D Ligand Expression in Nasopharyngeal Carcinoma and Hepatoma Cells. Journal of Immunotherapy 2017; 40(5): 164 doi: 10.1097/CJI.0000000000000168
|
| 95 |
Stephanie H. Greco, Kristen Spencer, Darren R. Carpizo. Precision Molecular Pathology of Liver Cancer. Molecular Pathology Library 2018; : 235 doi: 10.1007/978-3-319-68082-8_13
|
| 96 |
Rida Fatima Saeed, Uzma Azeem Awan, Sidra Saeed, Sara Mumtaz, Nosheen Akhtar, Shaista Aslam. Therapeutic Approaches in Cancer Treatment. Cancer Treatment and Research 2023; 185: 177 doi: 10.1007/978-3-031-27156-4_10
|
| 97 |
CHEOL PARK, JI-SUK JEONG, JIN-WOO JEONG, YONG-JOO KIM, YEON-KWON JUNG, GEUN-BAE GO, SUNG OK KIM, GI-YOUNG KIM, SU-HYUN HONG, YOUNG HYUN YOO, YUNG HYUN CHOI. Ethanol extract of Kalopanax septemlobus leaf induces caspase-dependent apoptosis associated with activation of AMPK in human hepatocellular carcinoma cells. International Journal of Oncology 2016; 48(1): 261 doi: 10.3892/ijo.2015.3233
|
| 98 |
L. V. K. S. Bhaskar, L. Saikrishna. Role of Tyrosine Kinases in Gastrointestinal Malignancies. 2018; : 191 doi: 10.1007/978-981-13-1486-5_14
|
| 99 |
Galina Khemlina, Sadakatsu Ikeda, Razelle Kurzrock. The biology of Hepatocellular carcinoma: implications for genomic and immune therapies. Molecular Cancer 2017; 16(1) doi: 10.1186/s12943-017-0712-x
|
| 100 |
Ivan Haralampiev, Holger A. Scheidt, Tobias Abel, Madlen Luckner, Andreas Herrmann, Daniel Huster, Peter Müller. The interaction of sorafenib and regorafenib with membranes is modulated by their lipid composition. Biochimica et Biophysica Acta (BBA) - Biomembranes 2016; 1858(11): 2871 doi: 10.1016/j.bbamem.2016.08.014
|
| 101 |
Chaoting Zeng, Wenting Shang, Xiaoyuan Liang, Xiao Liang, Qingshan Chen, Chongwei Chi, Yang Du, Chihua Fang, Jie Tian. Cancer Diagnosis and Imaging-Guided Photothermal Therapy Using a Dual-Modality Nanoparticle. ACS Applied Materials & Interfaces 2016; 8(43): 29232 doi: 10.1021/acsami.6b06883
|
| 102 |
Xinjun Dong, Feiyan Liu, Mianli Li. Inhibition of nuclear factor κB transcription activity drives a synergistic effect of cisplatin and oridonin on HepG2 human hepatocellular carcinoma cells. Anti-Cancer Drugs 2016; 27(4): 286 doi: 10.1097/CAD.0000000000000329
|
| 103 |
Haofeng Lu, Lin Zhou, Hongping Zuo, Wenjin Le, Jianfei Hu, Tiequan Zhang, Mi Li, Yufeng Yuan. Ivermectin synergizes sorafenib in hepatocellular carcinoma via targeting multiple oncogenic pathways. Pharmacology Research & Perspectives 2022; 10(3) doi: 10.1002/prp2.954
|
| 104 |
Da Huo, Jianfeng Zhu, Guojun Chen, Qian Chen, Chao Zhang, Xingyu Luo, Wei Jiang, Xiqun Jiang, Zhen Gu, Yong Hu. Eradication of unresectable liver metastasis through induction of tumour specific energy depletion. Nature Communications 2019; 10(1) doi: 10.1038/s41467-019-11082-3
|
| 105 |
Afza Ahmad, Rohit Kumar Tiwari, Saleha Siddiqui, Muskan Chadha, Ratnakar Shukla, Vivek Srivastava. Targeting Signaling Pathways in Solid Tumors - Part A. International Review of Cell and Molecular Biology 2024; 385: 41 doi: 10.1016/bs.ircmb.2023.11.006
|
| 106 |
HAN ZHAO, JING GUO, QINGJIA CHI, MENG FANG. Molecular mechanisms of Tanshinone IIA in Hepatocellular carcinoma therapy via WGCNA-based network pharmacology analysis. BIOCELL 2022; 46(5): 1245 doi: 10.32604/biocell.2022.018117
|
| 107 |
Shruthi Kanthaje, Ankita Makol, Anuradha Chakraborti. Sorafenib response in hepatocellular carcinoma: MicroRNAs as tuning forks. Hepatology Research 2018; 48(1): 5 doi: 10.1111/hepr.12991
|
| 108 |
An Li, Ning Wu, Jingyu Sun. E2F1‑induced microRNA‑224‑5p expression is associated with hepatocellular carcinoma cell migration, invasion and epithelial‑mesenchymal transition via MREG. Oncology Letters 2022; 23(3) doi: 10.3892/ol.2022.13202
|
| 109 |
Nicoletta Depalo, Rosa Maria Iacobazzi, Gianpiero Valente, Ilaria Arduino, Silvia Villa, Fabio Canepa, Valentino Laquintana, Elisabetta Fanizza, Marinella Striccoli, Annalisa Cutrignelli, Angela Lopedota, Letizia Porcelli, Amalia Azzariti, Massimo Franco, Maria Lucia Curri, Nunzio Denora. Sorafenib delivery nanoplatform based on superparamagnetic iron oxide nanoparticles magnetically targets hepatocellular carcinoma. Nano Research 2017; 10(7): 2431 doi: 10.1007/s12274-017-1444-3
|
| 110 |
Jie Qiao, Jie Liu, Kaiqiao Jia, Ning Li, Bin Liu, Qingyu Zhang, Runzhi Zhu. Diosmetin triggers cell apoptosis by activation of the p53/Bcl-2 pathway and inactivation of the Notch3/NF-κB pathway in HepG2 cells. Oncology Letters 2016; 12(6): 5122 doi: 10.3892/ol.2016.5347
|
| 111 |
Giuseppe Tarantino, Paolo Magistri, Roberto Ballarin, Raffaele Di Francia, Massimiliano Berretta, Fabrizio Di Benedetto. Oncological Impact of M-Tor Inhibitor Immunosuppressive Therapy after Liver Transplantation for Hepatocellular Carcinoma: Review of the Literature. Frontiers in Pharmacology 2016; 7 doi: 10.3389/fphar.2016.00387
|
| 112 |
So Young Yoo, Narayanasamy Badrinath, Hyun Young Woo, Jeong Heo. Oncolytic Virus-Based Immunotherapies for Hepatocellular Carcinoma. Mediators of Inflammation 2017; 2017: 1 doi: 10.1155/2017/5198798
|
| 113 |
Lili Cao, Lijun Zhang, Xiang Zhao, Ye Zhang, Daolin Tang. A Hybrid Chalcone Combining the Trimethoxyphenyl and Isatinyl Groups Targets Multiple Oncogenic Proteins and Pathways in Hepatocellular Carcinoma Cells. PLOS ONE 2016; 11(8): e0161025 doi: 10.1371/journal.pone.0161025
|
| 114 |
Emanuele Rinninella, Lucia Cerrito, Irene Spinelli, Marco Cintoni, Maria Cristina Mele, Maurizio Pompili, Antonio Gasbarrini. Chemotherapy for Hepatocellular Carcinoma: Current Evidence and Future Perspectives. Journal of Clinical and Translational Hepatology 2017; (XX): 1 doi: 10.14218/JCTH.2017.00002
|
| 115 |
Shaimaa Yousef, Hashem O. Alsaab, Samaresh Sau, Arun K. Iyer. Development of asialoglycoprotein receptor directed nanoparticles for selective delivery of curcumin derivative to hepatocellular carcinoma. Heliyon 2018; 4(12): e01071 doi: 10.1016/j.heliyon.2018.e01071
|
| 116 |
Jisoo Kim, Jungmin Kim, Ge Gao, Yoo‐mi Choi, Jaewook Kim, Dong‐Woo Cho, Jae‐Ho Cheong, Jinah Jang. Bioprinted Organoids Platform with Tumor Vasculature for Implementing Precision Personalized Medicine Targeted Towards Gastric Cancer. Advanced Functional Materials 2024; 34(11) doi: 10.1002/adfm.202306676
|
| 117 |
Hongzhi Wang, Satheesh Ellipilli, Wen-Jui Lee, Xin Li, Mario Vieweger, Yuan-Soon Ho, Peixuan Guo. Multivalent rubber-like RNA nanoparticles for targeted co-delivery of paclitaxel and MiRNA to silence the drug efflux transporter and liver cancer drug resistance. Journal of Controlled Release 2021; 330: 173 doi: 10.1016/j.jconrel.2020.12.007
|
| 118 |
Qingqing Xiong, Mangmang Cui, Ge Yu, Jian Wang, Tianqiang Song. Facile Fabrication of Reduction-Responsive Supramolecular Nanoassemblies for Co-delivery of Doxorubicin and Sorafenib toward Hepatoma Cells. Frontiers in Pharmacology 2018; 9 doi: 10.3389/fphar.2018.00061
|
| 119 |
I-Tao Huang, Bijay Dhungel, Ritu Shrestha, Kim R. Bridle, Darrell H. G. Crawford, Aparna Jayachandran, Jason C Steel. Spotlight on Bortezomib: potential in the treatment of hepatocellular carcinoma. Expert Opinion on Investigational Drugs 2019; 28(1): 7 doi: 10.1080/13543784.2019.1551359
|
| 120 |
Zhi-Peng Sun, Jian Zhang, Li-Hong Shi, Xiu-Rong Zhang, Yu Duan, Wen-Fang Xu, Gong Dai, Xue-Jian Wang. Aminopeptidase N inhibitor 4cc synergizes antitumor effects of 5-fluorouracil on human liver cancer cells through ROS-dependent CD13 inhibition. Biomedicine & Pharmacotherapy 2015; 76: 65 doi: 10.1016/j.biopha.2015.10.023
|
| 121 |
Mi-Jin Kim, Yeon-Kyung Choi, Soo Young Park, Se Young Jang, Jung Yi Lee, Hye Jin Ham, Byung-Gyu Kim, Hui-Jeon Jeon, Ji-Hyun Kim, Jung-Guk Kim, In-Kyu Lee, Keun-Gyu Park. PPARδ Reprograms Glutamine Metabolism in Sorafenib-Resistant HCC. Molecular Cancer Research 2017; 15(9): 1230 doi: 10.1158/1541-7786.MCR-17-0061
|
| 122 |
Meng Niu, Duo Hong, Teng-Chuang Ma, Xiao-Wei Chen, Jin-Hang Han, Jun Sun, Ke Xu. Short-term and long-term efficacy of 7 targeted therapies for the treatment of advanced hepatocellular carcinoma. Medicine 2016; 95(49): e5591 doi: 10.1097/MD.0000000000005591
|
| 123 |
Jesmin Mondal, Anisur Rahman Khuda-Bukhsh. Cisplatin and farnesol co-encapsulated PLGA nano-particles demonstrate enhanced anti-cancer potential against hepatocellular carcinoma cells in vitro. Molecular Biology Reports 2020; 47(5): 3615 doi: 10.1007/s11033-020-05455-x
|
| 124 |
Robert F. Schwabe, Tom Luedde. Apoptosis and necroptosis in the liver: a matter of life and death. Nature Reviews Gastroenterology & Hepatology 2018; 15(12): 738 doi: 10.1038/s41575-018-0065-y
|
| 125 |
Tao Wang, Sicong Ma, Xingxing Qi, Xiaoyin Tang, Dan Cui, Zhi Wang, Jiachang Chi, Ping Li, Bo Zhai. Knockdown of the differentially expressed gene TNFRSF12A inhibits hepatocellular carcinoma cell proliferation and migration in vitro. Molecular Medicine Reports 2017; 15(3): 1172 doi: 10.3892/mmr.2017.6154
|
| 126 |
G. Perota, N. Zahraie, R. Dehdari Vais, M.H. Zare, N. Sattarahmady. Au/TiO2 nanocomposite as a triple-sensitizer for 808 and 650 nm phototherapy and sonotherapy: Synergistic therapy of melanoma cancer in vitro. Journal of Drug Delivery Science and Technology 2022; 76: 103787 doi: 10.1016/j.jddst.2022.103787
|
| 127 |
Novi Angeline, Sung-Sik Choo, Cheol-Hwi Kim, Suk Ho Bhang, Tae-Hyung Kim. Precise Electrical Detection of Curcumin Cytotoxicity in Human Liver Cancer Cells. BioChip Journal 2021; 15(1): 52 doi: 10.1007/s13206-021-00002-7
|
| 128 |
Guoxuan Qin, Mengjiao Dang, Huajun Gao, Hao Wang, Fengting Luo, Ruibing Chen. Deciphering the protein–protein interaction network regulating hepatocellular carcinoma metastasis. Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics 2017; 1865(9): 1114 doi: 10.1016/j.bbapap.2017.06.005
|